{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:28:06Z","timestamp":1778254086486,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2320-B-039-059"],"award-info":[{"award-number":["NSTC 113-2320-B-039-059"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2320-B-214-003-MY3"],"award-info":[{"award-number":["NSTC112-2320-B-214-003-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2320-B-039-063-MY3"],"award-info":[{"award-number":["NSTC112-2320-B-039-063-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2320-B-214-003-MY3"],"award-info":[{"award-number":["112-2320-B-214-003-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2320-B-039-063-MY3"],"award-info":[{"award-number":["112-2320-B-039-063-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU113-S-56"],"award-info":[{"award-number":["CMU113-S-56"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178648","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:19:16Z","timestamp":1770164356000},"page":"178648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dose-dependent biphasic reversal of ABC transporter\u2013mediated multidrug resistance by natural dihydrochalcone via P-glycoprotein suppression"],"prefix":"10.1016","volume":"1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-7720","authenticated-orcid":false,"given":"Yu-Ning","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Heng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-192X","authenticated-orcid":false,"given":"Po-Yu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hsuan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-4834","authenticated-orcid":false,"given":"Chin-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178648_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/978-981-13-7647-4_12","article-title":"ABC transporter-mediated multidrug-resistant cancer","volume":"1141","author":"Amawi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2026.178648_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.178648_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246203","article-title":"Natural products\/bioactive compounds as a source of anticancer drugs","volume":"14","author":"Asma","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.178648_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2407-9-242","article-title":"A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models","volume":"9","author":"Boumendjel","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2026.178648_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178648_bib6","article-title":"Bioactive components of Fissistigma cupreonitens","volume":"13","author":"Chen","year":"2018","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejphar.2026.178648_bib7","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1021\/acs.jmedchem.7b01154","article-title":"Small-molecule inhibitors of the CD40-CD40L costimulatory protein-protein interaction","volume":"60","author":"Chen","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178648_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106579","article-title":"Redefine the role of d-\u03b1-Tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein, multidrug resistance protein 1, and breast cancer resistance protein mediated cancer multidrug resistance","volume":"190","author":"Chen","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.178648_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118153","article-title":"2',6'-dihydroxy-3',4'-dimethoxydihydrochalcone counteracts cancer multidrug resistance by impeding STAT3 activation and ABC transporter-mediated drug efflux","volume":"188","author":"Chien","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178648_bib10","doi-asserted-by":"crossref","DOI":"10.37796\/2211-8039.1408","article-title":"Metformin induces autophagy of cisplatin-resistant human gastric cancer cells in addition to apoptosis","volume":"13","author":"Fang","year":"2023","journal-title":"Biomedicine"},{"key":"10.1016\/j.ejphar.2026.178648_bib11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/ci400195v","article-title":"Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein","volume":"53","author":"Ferreira","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2026.178648_bib12","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2026.178648_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25153364","article-title":"Overcoming multidrug resistance: Flavonoid and terpenoid nitrogen-containing derivatives as ABC transporter modulators","volume":"25","author":"Gon\u00e7alves","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178648_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.174.1.41","article-title":"Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis","volume":"174","author":"Hill","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2026.178648_bib15","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.178648_bib16","article-title":"Comparative study on the MDR reversal effects of selected chalcones","volume":"2011","author":"Ivanova","year":"2011","journal-title":"Int J Med Chem"},{"key":"10.1016\/j.ejphar.2026.178648_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmech.2019.05.027","article-title":"Natural products as multidrug resistance modulators in cancer","volume":"176","author":"Kumar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178648_bib18","first-page":"379","article-title":"Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer","volume":"19","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2026.178648_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2174\/092986710790514507","article-title":"The structure and functions of P-glycoprotein","volume":"17","author":"Li","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178648_bib20","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.7150\/ijbs.63125","article-title":"Discovery and validation of nitroxoline as a novel STAT3 inhibitor in drug-resistant urothelial bladder cancer","volume":"17","author":"Lin","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.178648_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10972-0","article-title":"Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function","volume":"7","author":"Lindamulage","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178648_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bmc.2007.10.006","article-title":"Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein","volume":"16","author":"Liu","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178648_bib23","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1073\/pnas.2010264117","article-title":"Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1","volume":"117","author":"Nosol","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.178648_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103537","article-title":"ATP-Binding cassette efflux transporters and MDR in cancer","volume":"28","author":"Pote","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2026.178648_bib25","article-title":"Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence","volume":"11","author":"Salehi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178648_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejphar.2026.178648_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113832","article-title":"Reversal of multidrug resistance by Fissistigma latifolium-derived chalconoid 2-hydroxy-4,5,6-trimethoxydihydrochalcone in cancer cell lines overexpressing human P-glycoprotein","volume":"156","author":"Teng","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178648_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.phymed.2016.01.008","article-title":"\u03b2-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function","volume":"23","author":"Teng","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.178648_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/acs.jmedchem.1c01272","article-title":"Discovery and characterization of potent dual P-Glycoprotein and CYP3A4 inhibitors: design, synthesis, Cryo-EM analysis, and biological evaluations","volume":"65","author":"Urgaonkar","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178648_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.apsb.2023.12.010","article-title":"Small-molecule agents for cancer immunotherapy","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.178648_bib31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1021\/acs.jnatprod.9b01022","article-title":"Licochalcone A selectively resensitizes ABCG2-Overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs","volume":"83","author":"Wu","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2026.178648_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217116","article-title":"Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment","volume":"598","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2026.178648_bib33","article-title":"Natural products in preventing tumor drug resistance and related signaling pathways","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178648_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2019.05.053","article-title":"Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance","volume":"180","author":"Yin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178648_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154669","article-title":"Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B","volume":"111","author":"Yin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.178648_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117486","article-title":"The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents","volume":"95","author":"Yu","year":"2023","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:20:22Z","timestamp":1777404022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926001305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"alternative-id":["S0014299926001305"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178648","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-dependent biphasic reversal of ABC transporter\u2013mediated multidrug resistance by natural dihydrochalcone via P-glycoprotein suppression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178648"}}